Background: Disease transmission can occurs easily by transfusion of blood and components therapy. So screening is mandatory for all donated blood units for five transfusion transmitted diseases. It is necessary to know the current trends in results of screening for TTI in Bangladesh. Objective: The present study was executed to assess the prevalence of infectious disease markers among donors at the blood bank of a tertiary care center, Sir Salimullah Medical College & Mitford Hospital at Dhaka. Materials and Methods: The study was a three year (2016)(2017)(2018) retrospective study. A total of 35,831 donors comprising of 32606(91%) males and 3225(9%) females were screened over 3 years. There are no paid donors, all are either voluntary or replacement donors. Data was accumulated and analyzed from blood bank records for all donors who were screened for various TTIs using respective immunological methods. Results: Mean percentage of these infections per year was found to be Hepatitis B surface antigen (HBsAg) was 1.27%, Hepatitis C virus (HCV) was 0.013%,HIV was 0.0028%, syphilis was 0.078% andmalarial parasite (MP) was 0.0028%.The overall seroreactivity in present study significantly diminished through successive years. Conclusions: The risk of transfusion transmissible infection (TTI) today is low but attention should be paid onmethods to ensure a safety blood supply. For that screening with a better selection of donors and use of sensitive screening tests including nucleic acid testing technology should be implemented.
Introduction
Transfusion of blood and its components is life saving as wellas it has life threatening hazards. With every unit of blood there is a 1% chance of transfusion associated problems including transfusion transmitted diseases. 1 Blood donation saves the lives of millions of people worldwide; however, the patients are at a potential risk of contracting transfusiontransmitted infections (TTIs), which in turn impose serious challenges to the medical providers for the availability of safe and affordable bloodproducts. 2 http://jmscr.igmpublication.org/home/ ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i7.60
The accurate figures of TTIs in our population are still unknown due to the lack of understanding, un-availability of screening tests, limited access to health facilities and the unavailability of surveillance systems. 3 Lots of known cases of post transfusion diseases that have been caused by Human immunodeficiency virus (HIV), Hepatitis B virus (HBV), Hepatitis C virus (HCV), Treponema Pallidum and Malaria parasites. Preventing the transmission of infectious diseases through blood transfusion in developing countries is difficult given that the resources required are not always available even when policies and strategies are in place. These strategies have been extremely effective but transmission of diseases still occurs, primarily because of the inability of the test to detect the disease in the pre seroconversion or 'window' phase of their infection, high cost of screening, a lack of funds and trained personnel, immunologically variant viruses, nonseroconverting chronic or immuno-silent carriers and inadvertent laboratory testing errors. Transfusion Transmitted Infections is still a major concern to patients, physicians and policy makers who wish to see a risk free blood supply. 4 Pre-donation screening of blood donors for Transfusion Transmissible Infections (TTI) is the practice by which a prospective donor is tested for the presence of one or more of the TTI agents by a single rapid or quick method, and donation is deferred if the test is reactive for any of the TTI markers. 5 The aim of the present study was to find out prevalence of transfusion transmitted infections (TTI) in voluntary and replacement donors in our hospital transfusion service setup. This study also aids in evaluating the safety of the collected donations.
Materials and Methods
The study was done among all donors from the year 2016 up to 2018. All donors who had been selected to donate blood after the prospective donor had passed the haemoglobin check and the main exclusion criteria for donation, were screened for five mandatory tests for transfusion transmitted infections namely Hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV), HIV, syphilis, and malaria. Prevalence and trend of infectious disease markers was studied. The subjects included all replacement and voluntary blood donors. No professional donor was accepted. Written consent was taken from donors. Recommended exclusion criteria were: history of febrile or debilitating illness, weight loss, jaundice, hepatic or cardiovascular or pulmonary derangement, malignancy, epilepsy, bleeding diathesis, past blood transfusion, recent blood donation, consumption of prohibited drugs, surgical intervention, age under 18 or over 60 years, pregnancy or lactation. Screening tests were done by rapid test kits. Samples were found as reactive was rested for confirmation. All records were collected from blood bank records maintained as per Transfusion Medicine Department at SSMC & Mitford Hospital.
Results
A total of 35,831 donors donated blood over 3 years. The total number of donors who were found positive for transfusion transmissible infections (TTIs) was 491/35,831(1.37%) where males were dominant cohort. The male: female (M:F) ratio among the infected donor was15.36 :1(94% & 6%). (Figure 1 ) Altogether the highest prevalence for TTI was observed in the18-30 years age group (80%) followed by the 31-45 years (18%) and 2% in the 46-60years age group (Figure 2 ).In this study the seropositivity for various TTIs was found to be 456/491 (93%) for HBsAg, 5/491 for HCV (1%),1/491 (0.2%) for HIV, 28/491 (5.7%) for syphilis and 1/491 (0.2%) for malarial parasite (MP). (Figure 3 ) The mean percentage of these infections per year was found to be 1.27%, 0.013%, 0.0028%, 0.078% and 0.0028% for HBsAg, HCV,HIV, syphilis, and Malarial parasite respectively (Table 1 ). 
Discussion
Transfusion is a life-saving integral remedy in current medical practices, but also carries contemporary risk of transmitting dreadful TTIs like hepatitis B and C, HIV, Syphilis and less commonly to malaria, toxoplasmosis, brucellosis, other viral infections. 6 In the whole world, HBsAg (Hepatitis B surface antigen) prevalence varies between 0.1 and 11.7%. 7 Seroprevalence of HBsAg in various other Indian studies has been shown to range between 1.86 and 4%. 8, 9 Seroprevalence of HBsAg in various studies in Pakistan has been shown to range between 1.55 and 8.4% 10, 11 In the present study, the prevalence of TTIs was 1.37% whereas HBsAg was 1.27% which is 93% of all donors reactive for TTIs(Table1). The prevalence of HBsAg in a study in Khulna Medical College Hospital, Khulna was 1.39% 12 . In another study in Sir Salimullah Medical College, Dhaka the prevalence was 2.19%. 13 The similarity among results seems to be due to nearly identical socioeconomic condition among these regions. Universally around 3% people are infected with HCV. 14 Accordingly, worldwide 0.4-19.2% blood donors test positively for HCV. 15, 16, 17 In the present study the prevalence of sero-positivity for anti-HCV was 0.013% which is also low comparing theprevious findings. The prevalence of anti-HCV in a study by Ahmed et al 12 was 0.024%.In another study 13 at Sir Salimullah Medical College, Dhaka the prevalence was 0.25%. Extremely low anti-HCV prevalence 0% has been reported among the blood donors is UK and Scandinavia. 14 indicate that sero-prevalence of HCV ranges between 0.4 and 1.1%. Several studies in Pakistan showed that the sero-prevalence of HCV rangesbetween 0.07 and 4.9%. 10, 11 The possible explanation for variation in this results across studies might be due to increased awareness of not taking blood from professional donors along with differences in socio-cultural practices. In this study it has been found that the seroprevalence of HIV reactivity was 0.0028% which is very similar to Ahmed et al 12 , Saha et al 13 and Karim et al 19 in Bangladesh. The HIV seroprevalence in Indian scenario 20, 21 has been reported between 0.2 and 1%. Interestingly Pakistan has reported no transfusion transmitted HIV infection 10, 11 along with one study from Bangladesh 22 . In the present study, the VDRL was positive in 0.078% donor blood. The prevalence of VDRL in a study 12 in Khulna Medical College Hospital, Khulna was 0.00%. In another study 13 in Sir Salimullah Medical College, Dhaka the prevalence was 0.17%. In this study seroprevalence of Malaria among donors was 0.0028%. A study from Bangladesh 22 has showed 0.00% and another study by Karim 19 0.010% malaria present among their donors whereas a study from India 21 showed a prevalence of 0.107%.Very low incidence of HIV, Malaria and Syphilis in our study may reflect knowledgeable blood donors with better understanding of blood safety, effective outcome due to avoidance of paid donors and also better sensitive screening tests used countrywide during last few years reducing potentially dangerous donors. The overall seroprevalence of five TTIs among the studied donors figured out as 1.37% with a significant dwindling trend over successive years as1.69% in 2016,1.41% in 2017and 1.12% in 2018. (Figure 4& Table1) . Previous studies from Bangladesh showed prevalence of 1.42% 11 and 1.45% 22 .The results are identical probably due to demographic similarity. Male donors are more seropositive (94%). A study from Ethiopia showed nearly equal M:F=8.9%:7.1%. 23 Presence of more male directed blood donors than females is most probable cause for such a high ration of ours. Highest prevalence of TTI were seen among 18-30 years age group (80%) in our study with 20% in greater than 30 years of age. This findings is much high than Ethiopian study showed 23.6% TTI infected below age 30 years and 43.9% among age greater than 30. 23 Presence of more young donors in our blood bank than aged one is most probable cause for such high gap found.
Conclusion
Transfusion transmitted infections is an alarming thing that affect blood donors in Bangladesh, though with a significant downhill tendency in overall seroprevalence through the years, attention should be paid toward the prevention of hepatitis B virus. Donors who are between 18 and 30 years, usually significantly associated with TTIs as good as the voluntary and replacement donors do. Risk behavior based donor selection with proper donor education and better screening tests will provide more safe blood free from TTIs. Strict selections of blood donors are highly recommended.
